Mar 18, 2020   SOURCE: PR NewsWire

Influenzavirus B Infections Clinical Trials Review H1, 2020

DUBLIN, March 18, 2020 /PRNewswire/ -- The "Influenzavirus B Infections Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

This clinical trial report, Influenzavirus B Infections Global Clinical Trials Review H1, 2020 provides an overview of Influenzavirus B Infections Clinical trials scenario.

This report provides top line data relating to the clinical trials on Influenzavirus B Infections. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Report Scope

    --  The report provides a snapshot of the global clinical trials landscape
    --  Report provides top level data related to the clinical trials by Region,
        Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point
        status
    --  The report reviews top companies involved and enlists all trials (Trial
        title, Phase, and Status) pertaining to the company
    --  The report provides all the unaccomplished trials (Terminated, Suspended
        and Withdrawn) with reason for unaccomplishment
    --  The Report provides enrollment trends for the past five years
    --  Report provides latest news for the past three months

Reasons to Buy

    --  Assists in formulating key business strategies with regards to
        investment
    --  Helps in identifying prominent locations for conducting clinical trials
        which saves time and cost
    --  Provides top level analysis of Global Clinical Trials Market which helps
        in identifying key business opportunities
    --  Supports understanding of trials count and enrollment trends by country
        in global therapeutics market
    --  Aids in interpreting the success rates of clinical trials by providing a
        comparative scenario of completed and uncompleted (terminated, suspended
        or withdrawn) trials
    --  Facilitates clinical trial assessment of the indication on a global,
        regional and country level

Key Topics Covered

    1. Report Guidance
    2. Clinical Trials Report Coverage
    3. Clinical Trials by Region
    4. Clinical Trials and Average Enrollment by Country
    5. Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    6. Top Five Countries Contributing to Clinical Trials in Europe
    7. Top Countries Contributing to Clinical Trials in North America
    8. Top Countries Contributing to Clinical Trials in Middle East and Africa
    9. Top Five Countries Contributing to Clinical Trials in Central and South
       America
    10. Clinical Trials by G7 Countries: Proportion of Influenzavirus B
        Infections to Infectious Disease Clinical Trials
    11. Clinical Trials by Phase in G7 Countries
    12. Clinical Trials in G7 Countries by Trial Status
    13. Clinical Trials by E7 Countries: Proportion of Influenzavirus B
        Infections to Infectious Disease Clinical Trials
    14. Clinical Trials by Phase in E7 Countries
    15. Clinical Trials in E7 Countries by Trial Status
    16. Clinical Trials by Phase
    17. In Progress Trials by Phase
    18. Clinical Trials by Trial Status
    19. Clinical Trials by End Point Status
    20. Subjects Recruited Over a Period of Time
    21. Clinical Trials by Sponsor Type
    22. Prominent Sponsors
    23. Top Companies Participating in Influenzavirus B Infections Therapeutics
        Clinical Trials
    24. Prominent Drugs
    25. Clinical Trial Profile Snapshots

Companies Mentioned 

    --  GlaxoSmithKline Plc
    --  Shionogi & Co Ltd
    --  Daiichi Sankyo Co Ltd
    --  AstraZeneca Plc
    --  BioCryst Pharmaceuticals Inc
    --  F. Hoffmann-La Roche Ltd
    --  Vaxart Inc
    --  BioCryst UK Ltd
    --  ID Biomedical Corporation (Inactive)
    --  CSL Ltd

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/7i6u1f

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/influenzavirus-b-infections-clinical-trials-review-h1-2020-301026234.html

SOURCE Research and Markets